Sirtuins as therapeutic targets of ALS

Cell Research

Volumn 23, Issue 9, 2013, Pages 1073-1074

  Pasinetti, Giulio Maria ^a,b   Bilski, Amanda E ^a   Zhao, Wei ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; RESVERATROL; SIRTUIN; STILBENE DERIVATIVE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; CELL NUCLEUS; CYTOPLASM; DRUG EFFECT; HUMAN; METABOLISM; MITOCHONDRION; MOUSE; NOTE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELL NUCLEUS; CYTOPLASM; ENZYME INHIBITORS; HUMANS; MICE; MITOCHONDRIA; SIRTUINS; STILBENES;

EID: 84883447356     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2013.94     Document Type: Note

References (10)

1. Qin W, Yang T, Ho L, et al. J Biol Chem 2006; 281:21745-21754.
2. Giralt A, Hondares E, Villena JA, et al. J Biol Chem 2011; 286:16958-16866.
3. Zhao W, Varghese M, Yemul S, et al. Mol Neurodegener 2011; 6:51.
4. Viswanathan M, Guarente L. Nature 2011; 477:E1-E2.
5. Swerdlow RH, Parks JK, Cassarino DS, et al. Exp Neurol 1998; 153:135-142.
6. Zhao W, Varghese M, Vempati P, et al. PLoS One 2012; 7:e49191.
7. Han S, Choi JR, Soon Shin K, et al. Brain Res 2012; 1483:112-117.
8. Korner S, Boselt S, Thau N, et al. Neurode-gener Dis 2013; 11:141-152.
9. Song W, Song Y, Kincaid B, et al. Neurobiol Dis 2013; 51:72-81.
10. Shimazu T, Hirschey MD, Hua L, et al. Cell Metab 2010; 12:654-661.